1251302-89-2

Upstream product

• 6954-78-5 1-bromo-3-(2,4-dichlorophenoxy)propane 
• 120-83-2 2,4-dichlorophenol 

Downstream Products

• 1421333-90-5 tert-butyl 3-(2,4-dichlorophenoxy)propylcarbamate 
• 1421333-94-9 S-3-((3-(2,4-dichlorophenoxy)propyl)(prop-2-ynyl)amino)propane-1-thiol 
• 1421333-93-8 S-3-((3-(2,4-dichlorophenoxy)propyl)(prop-2-ynyl)amino)propyl ethanethioate 
• 1421333-92-7 N-(3-(2,4-dichlorophenoxy)propy)prop-2-yn-1-aminium 2,2,2-trifluoroacetate 
• 1421333-91-6 tert-butyl 3-(2,4-dichlorophenoxy)propyl(prop-2-ynyl)carbamate 
• 50911-63-2 3-(2,4-dichlorophenoxy)propan-1-amine 
• 1052548-74-9 3-(2,4-dichlorophenoxy)propan-1-amine hydrochloride 
• 1310538-18-1 N₆-(3-(2,4-dichlorophenoxy)propyl)-2-phenyl-1,2-dihydro-1,3,5-triazine-4,6-diamine hydrochloride 

Relevant academic research and scientific papers

MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER

A mechanism of monoamine oxidases (MAOs) driven epithelium-to-mesenchymal transition (EMT) is disclosed. Also disclosed are methods for treating cancer by inhibiting or suppressing MAOs in cancer cells. Novel MAOs inhibitors, such as small molecules, siRN

Expeditious synthesis and biological evaluation of novel 2,N 6-disubstituted 1,2-dihydro-1,3,5-triazine-4,6-diamines as potential antimalarials

A small set of novel 2,N6-disubstituted 1,2-dihydro-1,3,5- triazine-4,6-diamines was prepared possessing a flexible tether between the exocyclic nitrogen bonded to C-6 of the 1,2-dihydro-1,3,5-triazine-4,6-diamine heterocycle and the distal ary